Search results for

Wragge & Co partner Gordon Harris looks at recent developments at the ECJ, focusing in particular on deliberations in the O2 and H3G case

Thailand has recently adopted new legislation on product liability. The Unsafe Goods Liability Act, which will come into effect in February 2009, was designed to protect consumers who incur damage from defective products by imposing strict liability on those involved in the production and sale of the products.

In order to restrain a party from going forward with an infringing act, in Taiwan, a patentee may seek preliminary injunction against said party according to Article 538 of the Code of Civil Procedure before or pending the disposition of a litigation.

The Free Trade Agreement between Peru and the US came into force on December 4 2007.

The Saudi Trade Mark Law sets out the rights of a trade mark owner in Saudi Arabia against infringement. Since the law provides protection against infringement only for registered trade marks in Saudi Arabia, unregistered trade marks cannot be enforced. Administrative and legal actions are available against trade mark infringement in Saudi Arabia.

IP jurisprudence in Singapore is maturing well. Winnie Tham and Jason Chan of Amica Law highlight two key cases by way of illustration

Frances Chen of Tai E International offers some case reviews with a spotlight on trade mark examination guidelines

Michael Koch and R N Gnanapragasam of Ella Cheong Spruson & Ferguson explain how patentees can make use of the recent Patent Law changes in Singapore

In Common Services Agency v Scottish Information Commissioner, the House of Lords has ruled on the extent to which anonymised information about individuals constitutes "personal data" for the purposes of the Data Protection Act 1998. The decision makes clear that, in keeping with the EU Directive from which the UK's data protection legislation is derived, disclosure of fully anonymised personal information does not amount to processing of personal data which must be carried out in accordance with the data protection principles.

As discussed in Managing IP's March edition, it was becoming increasingly unclear whether method of diagnosis claims were allowable in New Zealand. However, Biosite Incorporated, a recently released decision of the Commissioner of Patents [P31/2007], may assist in clarifying practice in New Zealand.